[go: up one dir, main page]

GR3015634T3 - Process for the preparation of micronised biodegradable particles. - Google Patents

Process for the preparation of micronised biodegradable particles.

Info

Publication number
GR3015634T3
GR3015634T3 GR950400712T GR950400712T GR3015634T3 GR 3015634 T3 GR3015634 T3 GR 3015634T3 GR 950400712 T GR950400712 T GR 950400712T GR 950400712 T GR950400712 T GR 950400712T GR 3015634 T3 GR3015634 T3 GR 3015634T3
Authority
GR
Greece
Prior art keywords
micronised
preparation
biodegradable particles
biodegradable
particles
Prior art date
Application number
GR950400712T
Other languages
English (en)
Inventor
Bernd Dr-Dipl-Chem Zierenberg
Gojko Dr Muacevic
Original Assignee
Boehringer Ingelheim Kg
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg, Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Kg
Publication of GR3015634T3 publication Critical patent/GR3015634T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GR950400712T 1989-05-31 1995-03-27 Process for the preparation of micronised biodegradable particles. GR3015634T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3917617A DE3917617A1 (de) 1989-05-31 1989-05-31 Mikronisierte bioabbaubare partikel, verfahren zur ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
GR3015634T3 true GR3015634T3 (en) 1995-06-30

Family

ID=6381699

Family Applications (1)

Application Number Title Priority Date Filing Date
GR950400712T GR3015634T3 (en) 1989-05-31 1995-03-27 Process for the preparation of micronised biodegradable particles.

Country Status (9)

Country Link
US (1) US5871771A (el)
EP (1) EP0400522B1 (el)
JP (1) JP3002499B2 (el)
AT (1) ATE116541T1 (el)
CA (1) CA2017851C (el)
DE (2) DE3917617A1 (el)
DK (1) DK0400522T3 (el)
ES (1) ES2066038T3 (el)
GR (1) GR3015634T3 (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4041563A1 (de) * 1990-12-22 1992-06-25 Sanol Arznei Schwarz Gmbh Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
JPH06212726A (ja) * 1993-01-13 1994-08-02 Natl House Ind Co Ltd 家屋の妻面構造
US5780213A (en) * 1993-12-22 1998-07-14 Fuji Photo Film Co., Ltd. Photographic printing paper support
HUT77373A (hu) * 1994-09-29 1998-03-30 Andaris Limited Porlasztva szárított mikrorészecskék gyógyszerészeti hordozóként
US6126919A (en) * 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
TW577758B (en) 1997-10-27 2004-03-01 Ssp Co Ltd Intra-articular preparation for the treatment of arthropathy
AU2001243635A1 (en) * 2000-03-14 2001-09-24 Brown University Research Foundation Methods and compositions for regulating memory consolidation
EP1296651B2 (en) 2000-06-27 2019-07-17 Vectura Limited Method of making particles for use in a pharmaceutical composition
DK1296651T3 (da) * 2000-06-27 2008-02-11 Vectura Ltd Fremgangsmåde til fremstilling af partikler til anvendelse i et farmaceutisk præparat
US6723190B1 (en) * 2000-10-27 2004-04-20 The United States Of America As Represented By The Secretary Of The Navy ESD sensitivity in titanium/boron compositions
DE10061932A1 (de) * 2000-12-13 2002-10-24 Pharmatech Gmbh Wirkstoffhaltige Mikropartikel und Verfahren zur Herstellung der Mikropartikel durch Abrasion
WO2003000156A1 (en) 2001-06-22 2003-01-03 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
JP4679822B2 (ja) 2002-03-13 2011-05-11 ノバルティス アーゲー 医薬微粒子
DE10218107A1 (de) * 2002-04-23 2003-11-20 Jenapharm Gmbh Verfahren zum Herstellen von Kristallen von Steroiden, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen
CN1902254A (zh) * 2003-12-30 2007-01-24 3M创新有限公司 医药组合物及其制备方法
JP2005206491A (ja) * 2004-01-21 2005-08-04 Medgel Corp 肺気腫を治療するための経肺投与用製剤
US7942867B2 (en) * 2005-11-09 2011-05-17 The Invention Science Fund I, Llc Remotely controlled substance delivery device
US8968787B2 (en) 2010-05-24 2015-03-03 Micro Powders, Inc. Composition comprising biodegradable polymers for use in a cosmetic composition
CN113384540B (zh) * 2021-07-22 2022-04-01 北京海泰天正医药科技有限公司 盐酸丙卡特罗颗粒组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3264782D1 (en) * 1981-10-16 1985-08-22 Sanol Arznei Schwarz Gmbh Medicinal formulation
US4818542A (en) * 1983-11-14 1989-04-04 The University Of Kentucky Research Foundation Porous microspheres for drug delivery and methods for making same
GB8613811D0 (en) * 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
CH665558A5 (en) * 1985-10-09 1988-05-31 Debiopharm Sa Phase sepn. prodn. of microcapsules for water soluble pharmaceuticals - using fluoro-substd. aliphatic hydrocarbon as non-solvent in the hardening stage
SE8601457D0 (sv) * 1986-04-01 1986-04-01 Draco Ab Compositions of liposomes and b?712-receptor active substances for inhalation
EP0318492A1 (en) * 1986-08-11 1989-06-07 Innovata Biomed Limited Pharmaceutical formulations comprising microcapsules
JPS63122620A (ja) * 1986-11-12 1988-05-26 Sanraku Inc ポリ乳酸マイクロスフエア及びその製造方法

Also Published As

Publication number Publication date
JPH0317014A (ja) 1991-01-25
EP0400522B1 (de) 1995-01-04
CA2017851C (en) 2001-11-20
DK0400522T3 (da) 1995-04-03
DE59008170D1 (de) 1995-02-16
ATE116541T1 (de) 1995-01-15
EP0400522A2 (de) 1990-12-05
US5871771A (en) 1999-02-16
JP3002499B2 (ja) 2000-01-24
ES2066038T3 (es) 1995-03-01
EP0400522A3 (de) 1992-10-14
DE3917617A1 (de) 1990-12-06
CA2017851A1 (en) 1990-11-30

Similar Documents

Publication Publication Date Title
GR3015634T3 (en) Process for the preparation of micronised biodegradable particles.
ZA887889B (en) Process for the manufacture of 1,1,1-trifluorodichloroethylene and 1,1,1,2-tetrafluorochloroethylene
HUT53362A (en) Process for producing substituted 1,3-oxathiolans and pharmaceutical compositions comprising same
GR3001619T3 (en) Process for the preparation of (2,2)-paracyclophane
HUT69063A (en) Process for the preparation of 1,4-disubstituted-5(4h)-tetrazolinones
EP0445589A3 (en) Process for the preparation of 1,4-alkylenediamines
EP0237735A3 (en) 3,7-disubstituted-3-cephem compounds and process for production of the same
GB2205830B (en) Process for the preparation of 1,2,5,6,9,10-hexabromocyclododecane
NZ229705A (en) Process for the production of 2,6-diethylnaphthalene
IL89430A0 (en) Process for the preparation of 4,4'-dibromodiphenyl
HU908437D0 (en) Process for the production of 10-(2'-hydroxy-3'-alcoxy-1,4,7-tris-carboxymethyl-1,4,7,10-tetraazacyclododecanes
HU908436D0 (en) Process for the production of 10-(2'-hydroxy-3"-polyoxaalkyl/1,4,7-tris-carboxymethyl-1,4,7,10-tetraazacyclododecanes
HU9200354D0 (en) Process for the production of 2-ethyl-4-/2'/-1h-1,2,3,4-tetrazole-5-yl/-biphenyl-4-yl/-metoxi/-kinoline-hydrocloride
EP0340391A3 (en) 1,4-disubstituted-2,3,4,6-tetrahydroxy-1,4-diphosphorinane and their oxides or sulfides
EP0389110A3 (en) Process for the preparation of 2'-deoxy-5-trifluoromethyl-beta-uridine
IL86646A (en) Process for the preparation of 5,11-di-and 5,6,11,12-tetraphenylnaphthacenes
EP0297296A3 (en) Process for the preparation of 2,2'-oxybisûn,n-dimethyl-ethylamine¨
HU904661D0 (en) 14,17-alpha-etheno- and -ethano-esthatrienes and process for producing these compounds as well as pharmaceutical preparatives containing them
EP0334097A3 (en) Process for the preparation of 4,4'-dihalogeno-bisphenyls
EP0297496A3 (en) Novel process for the preparation of 6,7-diacyl-7-deacetylforskolin derivatives
HUT53773A (en) Antidotums containing substituted 1,8-naphtiridine derivatives as aktive components and process for producing the active components
EP0421216A3 (en) Process for the preparation of 2,4, resp. 2,6 dihalo-aniline
IL92465A0 (en) Process for the preparation of 4,4'-dibromodiphenylether
EP0475272A3 (en) Process for the preparation of 2,3,5-trimethyl-p-benzoquinone
IL92948A0 (en) Process for the production of 2,4-diamino-6-piperidinyl-pyrimidine-3-n-oxide